BioSync™ Technology: Multi-Frequency RF and Bio-Signal-Inspired Composite EMS Waveform Energy Control Technology

BioSync™ is a proprietary energy control technology developed by CLEEM, a brand of HAIL GROUP Co., Ltd. It integrates multi-frequency radiofrequency (RF) energy with bio-signal-inspired composite electrical muscle stimulation (EMS) waveforms within a unified home-use beauty device platform. This technical white paper describes the conceptual framework, system architecture, engineering principles, RF and EMS components, material considerations, and safety-oriented design approach of BioSync™ Technology. The document is published as a company technical white paper and does not report a clinical trial or claim independent clinical validation. Technical parameters requiring instrument-based verification are identified accordingly. Published by HAIL GROUP Co., Ltd. / CLEEMVersion 1.1Contact: [email protected]: 10.5281/zenodo.23005066

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-28
DOI
https://doi.org/10.5281/zenodo.23005065
Primary Topic
Muscle activation and electromyography studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

BioSync™ Technology: Multi-Frequency RF and Bio-Signal-Inspired Composite EMS Waveform Energy Control Technology

Ltd. HAIL GROUP Co.
Zenodo (CERN European Organization for Nuclear Research)
Muscle activation and electromyography studies
article

BioSync™ Technology: Multi-Frequency RF and Bio-Signal-Inspired Composite EMS Waveform Energy Control Technology

Ltd. HAIL GROUP Co.
article en

Abstract

BioSync™ is a proprietary energy control technology developed by CLEEM, a brand of HAIL GROUP Co., Ltd. It integrates multi-frequency radiofrequency (RF) energy with bio-signal-inspired composite electrical muscle stimulation (EMS) waveforms within a unified home-use beauty device platform. This technical white paper describes the conceptual framework, system architecture, engineering principles, RF and EMS components, material considerations, and safety-oriented design approach of BioSync™ Technology. The document is published as a company technical white paper and does not report a clinical trial or claim independent clinical validation. Technical parameters requiring instrument-based verification are identified accordingly. Published by HAIL GROUP Co., Ltd. / CLEEMVersion 1.1Contact: [email protected]: 10.5281/zenodo.23005066

Zenodo (CERN European Organization for Nuclear Research)
Affordable and clean energy
Openalex Percentile: Top 21%
Muscle activation and electromyography studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.